---
layout: default
title: Aluminum Jateorhiza Calumba Root Onion Peumus Bold
parent: 僅模型預測 (L5)
nav_order: 278
evidence_level: L5
indication_count: 0
---

# Aluminum Jateorhiza Calumba Root Onion Peumus Bold
{: .fs-9 }

證據等級: **L5** | 預測適應症: **0** 個
{: .fs-6 .fw-300 }

---

## 目錄
{: .no_toc .text-delta }

1. TOC
{:toc}

---

<div id="pharmacist">

## 藥師評估報告

</div>

# Multi-Ingredient Botanical-Mineral Combination: Evaluation Cannot Be Completed

## One-Sentence Summary

This submission contains a multi-component herbal and mineral combination — including Jateorhiza calumba root, Peumus boldus leaf, Viola tricolor, Tilia x europaea flower, Semecarpus anacardium juice, onion, and aluminum — none of which have established original indications or US market authorizations on record.
The TxGNN model returned **no predicted new indications** for this compound, and all safety fields are absent.
As a result, a standard repurposing evaluation cannot be completed at this time.

---

## Quick Overview

| Item | Content |
|------|---------|
| Original Indication | None on record |
| Predicted New Indication | None — TxGNN returned no candidates |
| TxGNN Prediction Score | N/A |
| Evidence Level | L5 (model prediction only) — no predictions generated |
| US Market Status | Not marketed |
| Number of NDAs | 0 |
| Recommended Decision | **Hold** |

---

## Why No Prediction Was Generated

This drug entry is an unusual multi-ingredient combination spanning a mineral (aluminum), South American herbs (Peumus boldus, Jateorhiza calumba), an Ayurvedic ingredient (Semecarpus anacardium), and European botanicals (Tilia x europaea, Viola tricolor, onion).

TxGNN operates on a knowledge graph built around individual drug entities mapped to DrugBank IDs. Because this combination has **no DrugBank ID**, the model cannot anchor it to any node in the graph, and therefore produces no repurposing candidates.

Additionally, no original indications are documented, which removes the second anchor point that TxGNN normally uses to contextualize a drug's therapeutic scope. Without either anchor, the model has nothing to reason from.

This is not evidence that the combination is ineffective — it simply means the data infrastructure needed for graph-based prediction is not yet in place.

---

## Conclusion and Next Steps

**Decision: Hold**

**Rationale:**
TxGNN cannot generate repurposing predictions for this combination because it lacks a DrugBank ID and has no documented original indications, making knowledge-graph anchoring impossible. No clinical trial or literature evidence was retrieved, and all safety data is absent.

**To proceed, the following is needed:**

- **Decompose the combination**: Evaluate each ingredient (e.g., Peumus boldus, Viola tricolor) individually against DrugBank to obtain IDs; run TxGNN on each component separately
- **Establish original indication(s)**: Identify the therapeutic category this combination belongs to (e.g., digestive aid, anti-inflammatory) from pharmacopoeias or regulatory submissions in countries where it is marketed
- **Obtain MOA data**: Query DrugBank or literature for mechanism of action for each active ingredient
- **Source safety data**: Retrieve contraindications and drug interaction data from the package insert or regulatory filings in the country of origin
- **Re-run the evidence pipeline**: Once DrugBank IDs and original indications are established, resubmit the evidence pack for a full TxGNN evaluation
## Disclaimer

This content is for research purposes only and does not constitute medical advice.
Clinical validation is required before any clinical application.

---

